The quality-adjusted life-year (QALY) is a popular tool for value assessment but is flawed. This paper highlights potential solutions.
John Browne, PhD
Advertisement
Articles by John Browne, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis
2
Nerandomilast a "No-Brainer" for First-Line Pulmonary Fibrosis Therapy: Justin M. Oldham, MD, PhD, MS
3
New Insight on Biologic Initiation Patterns for Treating Severe Asthma
4
Science Under Attack: Experts Warn of Rising Threats to Research Integrity
5
